SEC 13F Intelligence

Tanaka Capital Management Inc / NUVB

Tanaka Capital Management Inc’s Nuvation Bio Inc Position

Does Tanaka Capital Management Inc own Nuvation Bio Inc (NUVB)? Yes — 901.8K shares worth $4M (+6.46% of its 13F portfolio) as of Q1 2026, up from 841.6K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
901.8K
% of Portfolio
+6.46%
Quarters Held
3
currently held

Position History NUVB

Reported value by quarter
Q3 ’25: $3MQ3 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026901.8K$4M+6.46%
Q4 2025841.6K$8M+13.76%
Q3 2025685.1K$3M+4.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tanaka Capital Management Inc’s full portfolio or all institutional holders of NUVB.